(Q40605985)

22 September 2017

title

Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors (English)

1 reference

22 September 2017

1 reference

ChEBI release 2020-05-28

1 reference

Kebudi R

1

1 reference

22 September 2017

Görgün O

2

1 reference

22 September 2017

Ayan I

3

1 reference

22 September 2017

Gürler N

4

1 reference

22 September 2017

Akici F

5

1 reference

22 September 2017

Töreci K

6

1 reference

22 September 2017

publication date

1 April 2001

1 reference

22 September 2017

published in

Pediatric Blood Cancer

1 reference

22 September 2017

volume

36

1 reference

22 September 2017

issue

4

1 reference

22 September 2017

page(s)

434-441

1 reference

Granulocytopenia and cancer therapy. Past problems, current solutions, future challenges

22 September 2017

cites work

1 reference

Approaching the controversies in antibacterial management of cancer patients

21 January 2018

1 reference

A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia

21 January 2018

1 reference

Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem

21 January 2018

1 reference

Ceftazidime compared with piperacillin and tobramycin for the empiric treatment of fever in neutropenic patients with cancer. A multicenter randomized trial. The Intercontinental Antimicrobial Study Group

21 January 2018

1 reference

A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients

21 January 2018

1 reference

1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America

21 January 2018

1 reference

Cefepime monotherapy for the empirical treatment of fever in granulocytopenic cancer patients

21 January 2018

1 reference

Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trial.

21 January 2018

1 reference

Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group.

21 January 2018

1 reference

A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Can

21 January 2018

1 reference

Failure of granulocyte-macrophage colony-stimulating factor to reduce febrile neutropenia in children with recurrent solid tumors treated with ifosfamide, carboplatin, and etoposide chemotherapy

21 January 2018

1 reference

Equivalent efficacies of meropenem and ceftazidime as empirical monotherapy of febrile neutropenic patients. The Meropenem Study Group of Leuven, London and Nijmegen

21 January 2018

1 reference

In-vitro activity of cefepime and other antimicrobials: survey of European isolates

21 January 2018

1 reference

American Society of Clinical Oncology. Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MPO.1107

1 reference

22 September 2017

1 reference